Policy & Legislation
News on government policy and legislation impacting life science and diagnostics.
NCI Director Sharpless Outlines Ideas to Aggressively Lower Cancer Deaths
At the AACR Annual Meeting, Sharpless said NCI should focus on improving early screening, access to trials, and development of advanced drugs to realize President Biden's goal of eradicating cancer.
UK's NICE Backs Tagrisso for First-, Second-Line EGFR-Positive Lung Cancer
NICE is reversing its earlier negative recommendation for the lung cancer drug after AstraZeneca agreed to provide it at a discount.
NICE, NHS England's Pandemic Guideline Gives Temporary Access to Precision Oncology Treatments
Premium
The guideline, in effect for three months, gives access to many molecularly informed indications that NICE previously found not cost-effective or that it hasn't yet reviewed.
Cancer, Pathology Organizations Developing Clinical Guidelines for MMR, MSI Testing
The groups have written draft recommendations and are now asking for public comment from pathologists and other stakeholders.
UK's NICE Will Not Recommend Osimertinib for Untreated Non-Small Cell Lung Cancer
Based on cost-effectiveness estimates and a lack of comparison against afatinib, NICE will recommend against using